Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation

被引:26
|
作者
Khurana, S. [1 ]
Jain, N. K. [2 ]
Bedi, P. M. S. [1 ]
机构
[1] Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar 143104, Punjab, India
[2] Dr Hari Singh Gour Vishwavidyalaya, Dept Pharmaceut Sci, Sagar, Madhya Pradesh, India
关键词
Analgesic; meloxicam; nanostructured lipid carriers; skin tolerance; storage stability; DRUG-DELIVERY; RHEUMATOID-ARTHRITIS; PHYSICOCHEMICAL PROPERTIES; PENETRATION ENHANCERS; TRANSDERMAL DELIVERY; NANOPARTICLES SLN; NLC; GEL; PERMEABILITY; FORMULATION;
D O I
10.3109/03639045.2014.950586
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aim: Our investigation was aimed to investigate the potential suitability of meloxicam-loaded nanostructured lipid carriers (MLX-NLC) gel for topical application. Main methods: MLX-NLC gel was prepared and in vivo skin penetration ability of the NLC gel was evaluated using confocal laser scanning microscopy. We studied the effect of MLX-NLC gel on the changes in lipid profile of skin to get an insight into its skin penetration enhancement mechanism. Acetic acid induced writhing test was performed to evaluate the analgesic effect. Drug concentration-time profile of MLX in rat plasma and skin after topical and oral treatment with MLX-NLC gel and oral MLX-solution, respectively, was observed. MLX-NLC gel was subjected to primary skin irritation test, sub-acute dermal toxicity study. Storage stability of MLX-NLC gel was also assessed for 90 days. Key findings: NLC gel was effective in permeating Rhodamine 123 to deeper layers of rat skin. Changes in skin lipid prolife were observed in the rat skin on treatment with MLX-NLC gel and the results supported skin lipid extraction as a possible penetration enhancement mechanism. MLX-NLC gel demonstrated sustained pain inhibitory effect. Pharmacokinetics study established that topical application of MLX-NLC gel had the potential to avoid systemic uptake and hence the risk of systemic adverse effects. MLX-NLC gel demonstrated good skin tolerability and biosafety. Excellent physical stability of nanogel was observed at 4 +/- 2 degrees C. Significance: The study revealed that NLC gel is a promising carrier system for the topical application of MLX without side effects.
引用
收藏
页码:1368 / 1375
页数:8
相关论文
共 50 条
  • [1] Formulation, optimization, and in-vivo evaluation of nanostructured lipid carriers loaded with Fexofenadine HCL for oral delivery
    Abdelhameed, Asmaa H.
    Abdelhafez, Wael A.
    Saleh, Kh, I
    Mohamed, Mohamed S.
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 74
  • [2] Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam
    Khurana, S.
    Bedi, P. M. S.
    Jain, N. K.
    [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 2013, 175 : 65 - 72
  • [3] Nanostructured lipid carriers for oral delivery of baicalin: In vitro and in vivo evaluation
    Luan, Jingjing
    Zheng, Fang
    Yang, Xiaoye
    Yu, Aihua
    Zhai, Guangxi
    [J]. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2015, 466 : 154 - 159
  • [4] Nanostructured Lipid Carriers Mediated Drug Delivery to Posterior Segment of Eye and their In-vivo Successes
    Singh, Amit Kumar
    Kumar, Manish
    Upadhyay, Prabhat Kumar
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (06) : 713 - 723
  • [5] Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam
    Khalil, Rawia M.
    Abd-Elbary, A.
    Kassem, Mahfoz A.
    Ghorab, Mamdouh M.
    Basha, Mona
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2014, 19 (03) : 304 - 314
  • [6] Novel anti-psoriatic nanostructured lipid carriers for the cutaneous delivery of luteolin: A comprehensive in-vitro and in-vivo evaluation
    Hatem, Shymaa
    El-Kayal, Maha
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 191
  • [7] Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir
    Seyfoddin, Ali
    Sherwin, Trevor
    Patel, Dipika V.
    McGhee, Charles N.
    Rupenthal, Ilva D.
    Taylor, John A.
    Al-Kassas, Raida
    [J]. CURRENT DRUG DELIVERY, 2016, 13 (06) : 923 - 934
  • [8] Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation
    El-Salamouni, Noha S.
    Farid, Ragwa M.
    El-Kamel, Amal H.
    El-Gamal, Safaa S.
    [J]. JOURNAL OF MICROENCAPSULATION, 2018, 35 (01) : 102 - 113
  • [9] Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject
    Joshi, Medha
    Pathak, Sulabha
    Sharma, Shobhona
    Patravale, Vandana
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 364 (01) : 119 - 126
  • [10] Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation
    Noorulla, K. M.
    Yasir, Mohd
    Muzaffar, Faizi
    Roshan
    Ghoneim, Mohammed M.
    Almurshedi, Alanood S.
    Tura, Abdurazak J.
    Alshehri, Sultan
    Gebissa, Teshome
    Mekit, Shimelis
    Ahmed, Mohammed Muqtader
    Zafar, Ameeduzzafar
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 67